Impairment of phagocytosis in chicken monocytes during aflatoxicosis

Immunohistochemical Detection of Aflatoxin in Lesions of Aflatoxin-producing Aspergillus flavus Infection

Aflatoxin produced by Aspergillus flavus is known to be strongly related to liver injury (hepatocellular carcinoma) and immune system damage involving leukocytes. This toxin suppresses both the cell-mediated immune system and macrophage function, and decreases the production of complement and interferon molecules.

PURPOSE

To evaluate the presence of aflatoxin in infectious lesions as well as how the toxin is taken up by leukocytes.

METHOD

Pathological specimens from a patient who died from aspergillosis caused by aflatoxin-producing A. flavus were used. Anti-aflatoxin B₁ antibody was reacted with paraffin-embedded lesion specimens from the heart, kidney, and thyroid gland of the patient and observed microscopically.

RESULT

Positive reactions were detected in fungal elements and leukocytes (neutrophils and macrophages) in inflammatory lesions.

CONCLUSION

Within the patient's body, A. flavus likely produced aflatoxin, which then was taken up by neutrophils and macrophages.These results suggest that leukocyte function and the immune mechanism are locally suppressed by aflatoxin.

The in vitro effects of aflatoxin B1 on physiological functions of swine alveolar macrophages

The toxic effects of aflatoxin B₁ (AFB₁ ) on the physiological functions of swine alveolar macrophages (SAM) were investigated. Freshly isolated SAM were incubated with various AFB₁ concentrations (1.6 × 10^-1  - 1.6 × 10⁵  nmol/L) and time periods, and their phagocytic ability, synthesis of DNA, RNA and protein, and cell activation by lipopolysaccharide (LPS), were analysed. Results demonstrated that a significant (p < .05) reduction (60%) in Staphylococcus aureus uptaken by SAM appeared 3 hr after AFB₁ (>16 nmol/L) treatment. The synthesis of DNA, RNA and protein were markedly reduced, among which DNA and protein synthesis were affected more noticeably. The activation of SAM by LPS was significantly (p < .05) suppressed when the concentration of AFB₁ reached 1.6 × 10³  nmol/L. In general, most of the analysed effects were more prominent as AFB₁ concentration or incubation period increased. Taken together, AFB ₁ could elicit significant adverse effects on the physiological functions of SAM. Exposure of pigs to aflatoxin-contaminated feed may increase their susceptibility to various secondary infections.

Differential Transcriptome Responses to Aflatoxin B₁ in the Cecal Tonsil of Susceptible and Resistant Turkeys

The nearly-ubiquitous food and feed-borne mycotoxin aflatoxin B₁ (AFB₁) is carcinogenic and mutagenic, posing a food safety threat to humans and animals. One of the most susceptible animal species known and thus a good model for characterizing toxicological pathways, is the domesticated turkey (DT), a condition likely due, at least in part, to deficient hepatic AFB₁-detoxifying alpha-class glutathione S-transferases (GSTAs). Conversely, wild turkeys (Eastern wild, EW) are relatively resistant to the hepatotoxic, hepatocarcinogenic and immunosuppressive effects of AFB₁ owing to functional gene expression and presence of functional hepatic GSTAs. This study was designed to compare the responses in gene expression in the gastrointestinal tract between DT (susceptible phenotype) and EW (resistant phenotype) following dietary AFB₁ challenge (320 ppb for 14 days); specifically in cecal tonsil which functions in both nutrient absorption and gut immunity. RNAseq and gene expression analysis revealed significant differential gene expression in AFB₁-treated animals compared to control-fed domestic and wild birds and in within-treatment comparisons between bird types. Significantly upregulated expression of the primary hepatic AFB₁-activating P450 (CYP1A5) as well as transcriptional changes in tight junction proteins were observed in AFB₁-treated birds. Numerous pro-inflammatory cytokines, TGF-β and EGF were significantly down regulated by AFB₁ treatment in DT birds and pathway analysis suggested suppression of enteroendocrine cells. Conversely, AFB₁ treatment modified significantly fewer unique genes in EW birds; among these were genes involved in lipid synthesis and metabolism and immune response. This is the first investigation of the effects of AFB₁ on the turkey gastro-intestinal tract. Results suggest that in addition to the hepatic transcriptome, animal resistance to this mycotoxin occurs in organ systems outside the liver, specifically as a refractory gastrointestinal tract.

Key roles of vitamins A, C, and E in aflatoxin B1-induced oxidative stress

Aflatoxins (Aspergillus flavus toxins) are one of the natural toxic molecules which are produced by a group of fungi called Aspergillus. Foods and drinks contaminated with aflatoxins cause global health and environmental problems. Today in many developing countries, these toxins are leading cause of some liver cancers and serious gastrointestinal problems. Aflatoxins, which are well known to be mutagenic, carcinogenic, hepatotoxic, and immunosuppressive, exert inhibitory effects on biological processes including DNA synthesis, DNA-dependent RNA synthesis, DNA repair, and protein synthesis. Aflatoxins B(1) (AFB(1)) is the most widespread oxidative agent of the aflatoxins. Numerous diverse compounds and extracts have been reported to reduce the aflatoxins induced oxidative stress in the body. Most of these inhibitors including phenylpropanoids, terpenoids, alkaloids, and vitamins are originally derived from plants. Among these, being essential biomolecules, vitamins are used as coenzymes in very significant biological reactions. They also function as nonenzymatic antioxidative agents protecting the cells from oxidative stress-induced toxicity and transformation. This chapter reviews the mechanism of AFB(1)-induced oxidative stress and focuses on the protective effects of vitamins A, C, and E on reducing this stress.

Effects of prolonged oral administration of aflatoxin B1 and fumonisin B1 in broiler chickens

The effects of prolonged oral administration of aflatoxin B1 (AFB1) and fumonisin B1 (FB1) mycotoxins were evaluated in broiler chickens from 21 to 42 d of age. A total of 192 birds were housed in experimental batteries and assigned to 32 cages, 6 birds per cage. The following treatments were applied: 1) 0 mycotoxins (control), 2) 10 mg of FB1, 3) 50 microg of AFB1, 4) 50 microg of AFB1 + 10 mg of FB1, 5) 350 microg of AFB1, 6) 350 microg of AFB1 + 10 mg of FB1, 7) 2,450 microg of AFB1, 8) 2,450 microg of AFB1 + 10 mg of FB1/kg of feed. Each treatment consisted of 4 replicates of 6 birds each. At the end of the trial, blood samples from 12 birds per treatment were collected, and the birds were necropsied. Compared with controls, the percentage of heterophils was lower (P < 0.05) in birds from groups receiving 50 microg of AFB1/kg + 10 mg of FB1/ kg and 2450 microg of AFB1/kg alone or in combination with FB1. A higher percentage of lymphocytes (P < 0.05) was observed in birds fed 50 microg of AFB1/kg + 10 mg of FB1/ kg, 350 microg of AFB1/kg, and 2,450 microg of AFB1/kg. A decrease in plasma albumin was observed only in birds fed 2,450 microg of AFB1/kg + 10 mg of FB1/kg. The liver of AFB1-treated birds had focal areas of necrosis and inflammatory infiltrates. In birds fed rations containing only 10 mg of FB1/kg, bile duct hyperplasia with fibrosis and a mononuclear infiltrate accompanied by trabecular derangement were observed. In contrast, in treatments in which FB1 was administered in combination, hepatic vacuolar degeneration was observed, and renal tissue presented corpuscles with increased cellular agglomeration, characterizing glomerulonephritis, and a clearly visible tubular epithelium with areas of degeneration and necrosis. The FB1 residues were detected in liver and in excreta of all FB1-treated groups, at levels that ranged from 0.013 to 0.051 mg/kg and from 1.19 to 2.79 mg/kg, respectively. Results indicated that FB1 and AFB1, singly or in combination at the levels evaluated, do not change markedly the hematological and serological parameters of broiler chickens, but may cause relevant lesions in liver and in kidneys.

Effects of aflatoxin and carotenoids on growth performance and immune response in mule ducklings

The purpose of this study was to investigate if carotenoids could alleviate the adverse effects caused by aflatoxin with respect to growth performance and immune response. In two experiments, a total of 320 mule ducklings were assigned to 5 treatments, i.e. control, aflatoxin B(1) (AFB(1)) 200 ppb, AFB(1) +beta-carotene (BC) 200 ppm, AFB(1)+BC 400 ppm, and AFB(1)+astaxanthin (AS) 200 ppm. In experiment 1, the addition of beta-carotene or astaxanthin in the diet containing AFB(1) 200 ppb resulted in a significant decrease in average daily gain as compared with the control. AFB(1) 200 ppb alone and the addition of BC or AS on top of AFB(1) resulted in a significantly lower daily feed intake than for the control group. There were no significant differences in relative organ weights among treatment groups. Both treatments of BC 400 ppm and AS 200 ppm had significantly more macrophages harvested per duck than the control and AFB(1) 200 ppb treatments. However, there were no significant differences among treatments in percentages of phagocytotic macrophages and number of Candida albican phagocytized by phagocytotic macrophages. In experiment 2, blood biochemical parameters and antibody titers were evaluated. There were no significant differences among treatments in total bilirubin content and alkaline phosphatase activity in the serum or in antibody titers against fowl cholera. However, AFB(1) treatment had the highest activities of AST and ALT in the serum. The addition of BC 400 ppm on top of AFB(1) significantly reduced ALT activity as compared with the AFB(1) 200 ppb treatment. These results suggest that carotenoids could provide a slightly toxic alleviating effect on growth performance, enhance the chemotaxis ability of macrophages, and reduce ALT activity elevated by AFB(1).

The individual and combined effects of fumonisin B1 and moniliformin on performance and selected immune parameters in turkey poults

Effects of feeding diets containing fumonisin B1 (FB1) and moniliformin (M), singly or in combination, on performance and immune response were evaluated in poults. Day-old poults were randomly assigned to one of four dietary treatments with four replicates of four poults each. Dietary treatments were 1) control; 2) 200 mg FB1, 0 mg M/kg diet; 3) 0 mg FB1, 100 mg M/kg diet; and 4) 200 mg FB1, 100 mg M/kg diet. In Experiment 1, poults were injected with 0.25 mL Newcastle disease virus (NDV) vaccine on Weeks 2 and 3 of the experiment, and anti-NDV antibody titers were measured 7 d after each injection. Compared with controls, poults fed FB1 had significantly lower (P < 0.05) secondary antibody response. Poults fed M and the combination of FB1 and M had significantly lower (P < 0.05) primary and secondary antibody response. Lower relative thymus weights were observed in poults fed diets containing FB1 or M. Decreased relative bursa and spleen weights were observed in poults fed M. In Experiment 2, poults were placed on dietary treatments for 3 wk. On Day 21, 2 x 10(6) peripheral lymphocytes were incubated with mitogens. Poults fed diets containing FB1 had a significantly lower (P < 0.05) proliferative response to mitogens in comparison to controls. In Experiment 3, poults were placed on the diets for 3 wk and were injected with 4.4 x 10(7) E. coli/kg body weight on Day 21. Significantly higher (P < 0.05) numbers of E. coli colonies were observed in the blood and tissue homogenates of poults fed M. In all three experiments, feed intake and body weight gains were significantly lower (P < 0.05) in turkeys fed diets containing M. Data from the present study suggest that FB1 and M are immunosuppressive in poults and that M not only suppresses immune response but also performance. However, neither synergistic nor additive effects between FB1 and M were observed for any of the parameters measured.

Effects of moniliformin on performance and immune function of broiler chicks

Three trials were conducted to evaluate the effect of moniliformin (M) on performance and immune function in chicks. Day-old chicks were randomly assigned to four dietary treatments (0, 50, 75, or 100 mg M/kg diet). In Trial 1, chicks were placed on treatments for 3 wk and were injected intravenously with 4.6 x 10(6) Escherichia coli on Day 21. Blood samples were collected at 60, 120, and 180 min after inoculation, and liver, spleen, and lung were collected at 180 min postinjection. Compared with control chicks, chicks fed 75 and 100 mg M/ kg diet had higher (P < 0.05) numbers of E. coli colonies in the circulation, liver, and spleen. In Trial 2, chicks were placed on diets for 4 wk and were injected with 0.5 mL Newcastle disease virus (NDV) vaccine intramuscularly on Weeks 2 and 3 of the experiment. The primary and secondary anti-NDV antibody titers were measured 7 d after each injection. Chicks fed 100 mg M/kg diet had lower (P < 0.05) secondary antibody titers than did control chicks. In Trial 3, lymphocyte proliferation in chicks exposed to M in vivo and in vitro was determined. Results of the in vivo study showed that cell proliferation in response to mitogens from control- and M-fed chicks did not differ (P > 0.05). For the in vitro study, lymphocyte proliferation decreased linearly (P < 0.01) with increased concentrations of M. In all three trials, chicks fed 100 mg M/kg diet had lower (P < 0.05) feed intake and weight gain than did control chicks. Data from the current study suggested that M decreased performance and immune response in chicks at the level of 75 mg/kg diet.

Effects of fumonisin B1 on selected immune responses in broiler chicks

Three experiments were conducted to evaluate immune responses in chicks fed fumonisin B1 (FB1). Day-old male chicks were randomly allotted to dietary treatments: 0, 50, 100, or 200 mg FB1/kg diet. In Experiment 1, chicks were fed diets for 3 wk and were injected intravenously with 4.6x10(6) Escherichia coli on Day 21. Blood samples were collected at 60, 120, and 180 min postinjection, and liver, spleen, and lung were collected after 180 min. Chicks fed 200 mg FB1/kg diet had significantly higher numbers of bacterial colonies in blood, spleen, and liver (P<0.05) than control chicks. In Experiment 2, chicks were placed on the diets for 4 wk and were injected with 0.5 mL inactivated Newcastle Disease virus vaccine on Weeks 2 and 3 of the experiment, and primary and secondary antibody titers were measured 7 d after each injection. The secondary antibody response in chicks fed 200 mg FB1/kg diet was significantly lower (P<0.05) than that of control chicks. In Experiment 3, lymphocyte proliferation in chicks exposed to FB1 in vivo or in vitro was determined. Results of the in vivo study showed that cell proliferation in response to mitogens was lower (P<0.05) in chicks fed 200 mg FB1/kg diet than in control chicks. For the in vitro study, cell proliferation was lower (P<0.05) when cells were exposed to > or = 2.5 microg FB1/mL. Data of the current study suggested that FB1 is immunosuppressive in chicks when present in the ration at 200 mg FB1/kg diet.

Secondary metabolites of Aspergillus exert immunobiological effects on human monocytes

This project focused on the effects of aflatoxin B1 (AFB1), a food-contaminating mycotoxin produced by fungi, genus Aspergillus, on the release and genetic expression of some important cytokines, i.e., (interleukin-1 alpha (IL-1 alpha), IL-6, tumor necrosis factor-alpha (TNF alpha)) by human monocytes. Monocytes, preincubated for different time periods with concentrations of AFB1 ranging from 0.01 to 1.0 pg/mL, were then activated with bacterial lipopolysaccharide. Cytokine levels were measured by immunoassay and mRNA by cDNA amplification. Pretreatment of monocytes with AFB1 resulted in a decrease in IL-1, IL-6 and TNF alpha release already at a concentration of 0.05 pg/mL. The gene expression of the cytokines considered was drastically affected by treatment with AFB1. In fact, AFB1 completely blocked the transcription of IL-1 alpha, IL-6 and TNF alpha mRNAs, while it did not affect beta-actin mRNA at the concentrations used. It therefore appears that AFB1 exerts its effect on cytokine release through selective inhibition of specific mRNA, without affecting general protein synthesis.

4 beta, 15-Diacetoxyscirpenol induces cytotoxicity and alterations in phagocytic and Fc-receptor expression functions in chicken macrophages in vitro

4 beta, 15 Diacetoxyscirpenol (DAS) mycotoxin produced by Fusarium species was tested for detrimental effects on macrophage viability, phagocytosis, and Fc-receptor expression. Sephadex-elicited chicken abdominal cells were harvested to establish adherent macrophage monolayers on glass coverslips. Coverslips were then assigned randomly to treatment groups (0, 12.5 and 25 micrograms/mL DAS). Macrophage monolayers were exposed to treatments for 1 h, washed, and tested for various functional endpoints. Treatment with DAS resulted in decreased viability of macrophages (90.8% vs 81.5% vs 70.4% viable in the 0, 12.5 and 25 micrograms treatments, respectively) and decreased the percentage of macrophages phagocytizing sheep erythrocytes (81.6% vs 53.1% vs 46.0%. DAS also caused a decrease in the mean number of opsonized cells engulfed per phagocytic macrophage (5.7 vs 3.7 vs 2.9). A similar trend was observed using unopsonized sheep erythrocytes (15.4% vs 7.6% vs 5.5% phagocytic macrophages and 0.29 vs 0.11 vs 0.08 erythrocytes engulfed per macrophage). The incidence of Fc-receptor positive macrophages determined by sheep erythrocyte rosetting was also decreased in DAS-treated macrophages as compared to the control (49.2% vs 32.7% vs 24.2%). The findings of this study demonstrate that DAS exposure causes a suppression in macrophage phagocytic function and therefore may alter the first line of immunological defense in chickens.

Immunobiological activities of mould products: functional impairment of human monocytes exposed to aflatoxin B1

In order to elucidate the effects upon the human immune system of aflatoxin B1 produced by the food-contaminating mould Aspergillus flavus, phagocytosis, microbicidal activity, superoxide production and intrinsic antiviral activity were studied in monocytes exposed to aflatoxin B1 for different times at concentrations ranging from 0.1 to 1 pg/ml. Phagocytosis and microbicidal activity were significantly impaired (p < 0.05) by aflatoxin B1 at doses as low as 0.1 pg/ml. However, pretreatment of monocytes with aflatoxin B1 did not modify intrinsic antiviral activity or superoxide production. These results confirmed data obtained from animals fed with mycotoxin-contaminated foods. The potential danger to human health of exposure to mycotoxins demonstrates the necessity for careful microbiological control of food.

Phagocytic activity of two lines of chickens divergently selected for antibody production

Differences in phagocytic capacity of two chicken lines selected for high (H) or low (L) antibody response against sheep red blood cells (SRBC) were studied in 8 month old cocks of the seventh selection generation. The H line cocks had significantly higher agglutinin titers after immunization with SRBC than the L line. The total clearance capacity of the phagocytes, measured by the clearance of carbon particles from the blood, did not differ between the lines. The L line cocks had more circulating granulocytes. However, the granulocytes of the H line phagocytized more yeast cells than those of the L line. Neither in immunized nor in non-immunized cocks, were line differences found in the intracellular destruction of antigen by phagocytes, estimated as the superoxide production during phagocytosis and the plasma levels of lysozyme activity and acid phosphatase, before and after immunization. It was concluded that the line difference in antibody response was not due to measurable differences in phagocytic activity.

Functional impairment of rat Kupffer cells induced by aflatoxin B1 and its metabolites

Contamination of food with mycotoxins is a major health problem. Impairment of several immune functions has been repeatedly reported in animals fed with contaminated fodder. Since the liver is a major target of toxicity by aflatoxins, the effects of aflatoxins B1, and its hepatic metabolites Q1 and M1 on Kupffer cell function was investigated in vitro. Aflatoxin B1 induced significant (P < 0.05) inhibition of phagocytosis, intracellular killing of Candida albicans, and intrinsic anti-Herpes virus activity at concentrations as low as 0.01 pg ml-1. Aflatoxin Q1 and M1 had similar effects on phagocytosis and microbicidal activity, but were two- to ten-fold less potent than aflatoxin B1.

Destruction of phagocytosis-suppressing activity of aflatoxin B1 by ozone

The impact of ozone on the immunity-impairing activity of aflatoxin B1 (AFB1) was studied. Phagocytosis by rat peritoneal macrophages, which was found to be suppressed in the presence of AFB1, remained unimpaired when the applied AFB1 was pretreated with ozone (1.2 mg l-1) for 6 min at a flow rate of 40 ml min-1. Hence, application of ozone on AFB1-contaminated foodcrops seems to be a promising preventive measure against any adverse immunological disorder in consumers.

The effects of direct and microsomal activated aflatoxin B1 on chicken peritoneal macrophages in vitro

Sephadex-elicited peritoneal exudate cells were cultured on glass coverslips in order to determine the effects of aflatoxin B1 (AFB1) on chicken macrophages. Adherent macrophage monolayers were exposed for 1 h to 5, 10, and 20 micrograms ml-1 of AFB1, directly or to 0.01, 0.1, 0.5, 1, and 5 micrograms ml-1 of AFB1 in the presence of a chicken microsomal mixed function oxidase system (MFO). After exposure, the macrophage cultures were washed and allowed to recover for 2 h in fresh culture medium. Parameters measured at 2 h post recovery period were the substrate adherence potential, morphological alterations, phagocytic ability, and number of sheep red blood cells (SRBC) internalized per phagocytic macrophage. Direct in vitro exposure to AFB1 resulted in a dose-dependent decrease in macrophage adherence potential, and an increase in cell damage as determined by nuclear disintegration and cytoplasmic blebbing, but no detrimental effects were observed on percent phagocytic cells or the number of internalized SRBC. However, significant reductions in adherence potential, increased morphological alterations, and reduced phagocytosis and internalization of SRBC were observed when MFOs were added to cultures treated with much lower doses of AFB1. Addition of piperonyl butoxide (a P-450 inhibitor) abrogated AFB1-MFO induced alterations. This study suggests that microsomal activated AFB1 causes significant alterations in chicken macrophage functions.

Effect of fumonisin-B1 exposure on chicken macrophage functions in vitro

Fumonisin-B1 (FB1) is one of the recently discovered metabolites of Fusarium moniliforme (Sheldon) occurring naturally in infected corn. It is hepatocarcinogenic and causes death in several animal species including rats, horses, swine, and ducklings. In the present study, chicken peritoneal macrophages (PM) and a chicken macrophage cell line, MQ-NCSU, were exposed in vitro to various doses of FB1. Exposure to .5, 5, and 10 micrograms FB1/mL caused significant cytotoxicity in PM after 2 and 4 h of exposure. Morphological alterations induced by FB1 in PM included cytoplasmic blebing or nuclear disintegration or both, which were maximal in cultures treated with 20 micrograms FB1/mL. Significant depression in the phagocytic potential of PM occurred after 4 h treatment with 20, 40, and 100 micrograms FB1. However, exposure to FB1 alone, as well as after stimulation with lipopolysaccharide, induced secretion of a cytolytic factor by MQ-NCSU cells. These findings, which showed that FB1 exposure induced morphological and functional alterations in chicken macrophages, imply that FB1 exposure may result in increased susceptibility of chickens to bacterial infection.

Effect of aflatoxins on rat peritoneal macrophages

Phagocytosis, intracellular killing of Candida albicans, and superoxide production by rat peritoneal macrophages exposed to aflatoxins B1, B2, G1, G2, B2a, and M1 at several times and concentrations were analyzed to evaluate the intensity of a depressive effect for each mycotoxin. All aflatoxins used at very low concentrations had a depressive effect on the functions of macrophages. The biggest impairment of phagocytosis, intracellular killing, and spontaneous superoxide production was observed in macrophages exposed to aflatoxins B1 and M1.

Increased sensitivity to staphylococcal beta hemolysins of erythrocytes from chickens during aflatoxicosis

The size of the zones of beta-hemolysis surrounding staphylococcal colonies on blood agar was found to be related to the level of dietary aflatoxin consumed by the chickens donating the blood. Zone sizes on blood from chickens fed the highest level of aflatoxin (10 micrograms/g of diet) were about six-fold larger than those on blood from control birds. The percentage of staphylococcal isolates displaying beta-hemolysis was increased from about 15% in normal blood to about 90% in blood from chickens fed aflatoxin (10 micrograms/g) whereas the time required for detection of beta-hemolysis was decreased by about one-half. The hemolytic activity of purified staphylococcal beta-hemolysin against suspensions of washed erythrocytes increased as the level of aflatoxin consumed by the donor chickens increased. These data imply a new mechanism for enhanced susceptibility of animals to infectious agents during mycotoxicoses whereby the animal is made more sensitive to the virulence factors of pathogens.

Progression of aflatoxicosis in broiler chickens

The progression of aflatoxicosis was evaluated in young broiler chickens (Hubbard X Hubbard). The experimental design consisted of four dietary treatments of aflatoxin (0, 1.25, 2.5, and 5.0 micrograms of aflatoxin/g of feed, ppm) and 11 replicates of 10 broilers/replicate. The broilers were maintained in electrically heated batteries with feed and water available ad libitum from hatching to 3 weeks of age. The broilers were weighed, bled, killed by cervical dislocation, and necropzied at 3, 6, 9, 12, 15, 17, and 21 days of age. Body weights were significantly decreased by 5.0 ppm aflatoxin at 6 days of age and by 2.5 ppm at 17 days of age. Aflatoxin induced a significant increase in the relative weight of the proventriculus, gizzard, spleen, and kidney. Liver atrophy was indicated in the early stages of aflatoxicosis by a decrease in the relative weight of this organ. As aflatoxicosis progressed, hepatomegaly became apparent due to lipid accumulation in the liver. Packed-cell volume and hemoglobin levels were significantly decreased by 5.0 ppm aflatoxin at 12 days and by 2.5 ppm aflatoxin at 21 days of age. Serum levels of albumin and total protein were significantly reduced at 5.0 and 2.5 ppm aflatoxin by 3 and 6 days of age, respectively. Serum levels of uric acid, triglycerides, and cholesterol were significantly decreased from control values from 12 through 21 days of age by 5.0 ppm aflatoxin and, to a lesser extent, by 2.5 ppm aflatoxin. The activity of serum lactic dehydrogenase was significantly decreased at all aflatoxin treatment levels from 12 through 21 days of age.(ABSTRACT TRUNCATED AT 250 WORDS)

Embryonic exposure to aflatoxin-B1: mutagenicity and influence on development and immunity

Chick embryos were mutagenized in ovo in order to study developmentally related alterations in immune functions in survivors of this prenatal toxicant insult. In this experimental system, a single exposure of 6-day chick embryos to 0.1 microgram aflatoxin-B1 (AF-B1) in 10 microliters of acetone was employed, and the control embryos received 10 microliters of solvent alone. This dosage of AF-B1 administered to 6-day embryos was found to increase the incidence of sister chromatid exchanges in blood cells approximately fivefold above the baseline observed in solvent controls. A second sham control, where no solvent was administered, was included in some experiments. The cell cycle times in blood increased slightly during the initial exposure to AF-B1. However, a majority of the AF-B1 and acetone exposed embryos survived and hatched without incident. Losses occurred mainly in the latter part of embryogenesis. After hatching, no significant differences were observed in body weight between different treatment groups up to 26 weeks of age and no change in primary humoral immunity was detected. In contrast, two parameters of cell-mediated immunity, graft vs host (GvH), and cutaneous basophil hypersensitivity (CBH) reactions were both depressed as a result of exposure to AF-B1. The AF-B1 treatment group was significantly reduced in the GvH reaction compared with sham-treated controls. In the CBH assay, AF-B1-exposed chicks showed reduced immunity compared with acetone controls. These results suggest that long-term selective immune depression can occur following embryonic exposure to AF-B1.

Avian peritoneal exudate cells: a comparison of stimulation protocols

The influence of different stimulation protocols on the induction of peritoneal exudate cells (PECs) and adherent cells, and on the percentage of different adherent cell types was examined in the chicken and Japanese quail. The results suggest that different protocols may be selected to maximize isolation of specific PEC populations for immunological studies. In the chicken, starch, peptone, glycogen, and Sephadex G-40 were all equally effective and superior to saline in generating PECs. While a single injection of Sephadex produced the highest yield of adherent cells with a maximum percentage of macrophages, repeated injections of Sephadex led to dramatic increases in non-adherent PECs (lymphocytes). In contrast, a single injection of starch was optimum for generating non-macrophage adherent cells (primarily heterophils). Since responses of the Japanese quail to stimulation with starch and saline were similar to those observed for the chicken, it is suggested that these protocols may be generally applicable for use with avian species.

Evaluation of immunity of young broiler chickens during simultaneous aflatoxicosis and ochratoxicosis

A 2 X 2 factorial experimental design consisting of the treatments 0 and 2.5 micrograms/g aflatoxin and 0 and 2.0 micrograms/g ochratoxin A with 12 replicates of 10 birds per treatment level was used to evaluate the effects of these mycotoxins on various aspects of immunity. Male chicks (Hubbard X Hubbard) were maintained on these treatments from one day of age to 3 weeks of age at which time six replicate pens per treatment were sacrificed and various parameters measured. The additional six replicate pens per treatment were maintained on toxin feed beyond 3 weeks of age, and at 4 weeks of age, three replicate pens were immunized with sheep red blood cells (SRBC) and Brucella abortus. Antibody titers were measured up to 10 days postimmunization. Aflatoxin and ochratoxin A, individually, significantly (P less than .05) decreased body weight, and a synergistic toxicity was evident by a significant (P less than .05) decrease in body weight. Antibody titers and phagocytic activity of heterophils were not significantly (P less than .05) altered by any treatments. The relative weight of the bursa of Fabricius and the number of follicles for a given area of the folds of the bursa of Fabricius were significantly (P less than .05) decreased only by the interaction treatment. Complement activity was significantly (P less than .05) decreased by aflatoxin and the combination of aflatoxin and ochratoxin A and depressed, although not significantly (P less than .05), by ochratoxin A.(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of low level chronic aflatoxicosis in broiler chickens

A completely random design consisting of three replicates of 25 broiler chickens (Hubbard x Hubbard) at each of four treatments was used to evaluate the effects of low level, chronic aflatoxicosis on performance and various processing parameters. The treatments in Trial 1 were control, .075, .225, and .675 and in Trial 2 control, .3, .9, and 2.7 micrograms/g toxin in feed (ppm). The chickens were maintained on these treatments from day-old to 7 weeks of age with feed and water available ad libitum. All aflatoxin dose levels in Trial 1 significantly (P less than .05) decreased live, dressed, and chilled eviscerated weight, whereas only 2.7 ppm significantly (P less than .05) decreased live and dressed weight in Trial 2, with chilled eviscerated weight being significantly (P less than .05) decreased at .3 and 2.7 ppm in Trial 2. Parts weights and dimension measurements reflected the aflatoxin-induced decrease in dressed weight. Breast yield (%) was significantly (P less than .05) decreased by aflatoxin while back, wing, drum, and thigh yields were significantly increased by aflatoxin. No effect of aflatoxin was seen on the incidence of crooked keel, feather follicle infection, breast blisters, or conformation. A hypocarotenoidemia and hepatic hyperlipemia were clearly a result of chronic aflatoxicosis in these broiler chickens. These data demonstrate that the toxicity of aflatoxin is dependent on the environment in which broiler chickens are exposed.(ABSTRACT TRUNCATED AT 250 WORDS)

Increased severity and new symptoms of infectious bursal disease during aflatoxicosis in broiler chickens

A factorial design for the presence and absence of infection with a mild strain of infectious bursal disease (IBD) virus and graded levels of dietary aflatoxin (0, .625, 1.25, 2.5, 5.0, and 10.0 microgram/g of diet) in young broiler chickens revealed several interactions which greatly changed and character of the IBD infection. An infection that was essentially free of mortality became lethal to about half the birds. A coagulopathy as indicated by prolonged prothrombin times and by the occurrence of slight hemorrhages in skeletal muscles, a hypoproteinemia, a hypocalcemia, and a markedly enlarged kidney were observed in combined aflatoxicosis and IBD, but not in IBD alone. The size of the bursa of Fabricius following an initial hypertrophy was atrophied 4 days after inoculation and the spleen was enlarged. The effects of aflatoxin and IBD on these two glands were additive. Packed blood cell volume and hemoglobin values were decreased by aflatoxin only. Thus, aflatoxin had the effects of making IBD a much more severe disease and of changing the symptoms.